THE CD3-ZETA CYTOPLASMIC DOMAIN MEDIATES CD2-INDUCED T-CELL ACTIVATION

被引:75
作者
HOWARD, FD
MOINGEON, P
MOEBIUS, U
MCCONKEY, DJ
YANDAVA, B
GENNERT, TE
REINHERZ, EL
机构
[1] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
关键词
D O I
10.1084/jem.176.1.139
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD2-mediated T lymphocyte activation requires surface expression of CD3-Ti, the T cell receptor (TCP) for antigen major histocompatibility complex protein. Given the importance of CD3-zeta in TCR signaling, we have directly examined the ability of the CD3-zeta cytoplasmic domain to couple CD2 to intracellular signal transduction pathways. A cDNA encoding a chimeric protein consisting of the human CD3-zeta cytoplasmic domain (amino acid residues 31-142) fused to the CD8-alpha extracellular and transmembrane domains (amino acid residues 1-187) was transfected into a CD2+CD3-CD8- variant of the human T cell line Jurkat. The resulting transfectants expressed the CD8-alpha/CD3-zeta chimeric receptor at the cell surface in the absence of other TCR subunits. Stimulation of these transfectants with anti-T11(2) + anti-T11(3) Monoclonal antibodies (mAbs) initiated both a prompt cytosolic free calcium ([Ca2+]i) rise and protein tyrosine kinase activation. Stimulation with either intact anti-T11(2) + anti-T11(3) mAbs or purified F(ab')2 fragments resulted in interleukin 2 (IL-2) secretion. In contrast, control cell lines transfected with a cDNA encoding wild-type CD8-alpha, and thus lacking surface expression of the CD3-zeta cytoplasmic domain, failed to show any [Ca2+]i rise, protein tyrosine kinase activation, or IL-2 secretion after identical stimulation. These data directly establish the CD3-zeta cytoplasmic domain as a necessary and sufficient component of the CD3-Ti complex involved in T lymphocyte activation through CD2. Moreover, they show that CD2 signaling can function in the absence of Fc receptors.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 27 条
[1]   INTERDEPENDENCE OF CD3-TI AND CD2 ACTIVATION PATHWAYS IN HUMAN LYMPHOCYTES-T [J].
ALCOVER, A ;
ALBERINI, C ;
ACUTO, O ;
CLAYTON, LK ;
TRANSY, C ;
SPAGNOLI, GC ;
MOINGEON, P ;
LOPEZ, P ;
REINHERZ, EL .
EMBO JOURNAL, 1988, 7 (07) :1973-1977
[2]   FUNCTIONAL AND MOLECULAR ASPECTS OF HUMAN LYMPHOCYTE-T ACTIVATION VIA T3-TI-PATHWAYS AND T11-PATHWAYS [J].
ALCOVER, A ;
RAMARLI, D ;
RICHARDSON, NE ;
CHANG, HC ;
REINHERZ, EL .
IMMUNOLOGICAL REVIEWS, 1987, 95 :5-36
[3]   T-CELL RECEPTOR-INDEPENDENT CD2 SIGNAL TRANSDUCTION IN FCR+ CELLS [J].
ARULANANDAM, ARN ;
KOYASU, S ;
REINHERZ, EL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :859-868
[4]   DIFFERENTIAL SIGNAL TRANSDUCTION VIA T-CELL RECEPTOR CD3-ZETA-2, CD3-ZETA-ETA, AND CD3-ETA-2 ISOFORMS [J].
BAUER, A ;
MCCONKEY, DJ ;
HOWARD, FD ;
CLAYTON, LK ;
NOVICK, D ;
KOYASU, S ;
REINHERZ, EL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) :3842-3846
[5]  
BOCKENSTEDT LK, 1988, J IMMUNOL, V141, P1904
[6]  
BREITMEYER JB, 1987, J IMMUNOL, V139, P2899
[7]  
CHANG HC, 1989, J EXP MED, V168, P2077
[8]   CD3-ETA AND CD3-ZETA ARE ALTERNATIVELY SPLICED PRODUCTS OF A COMMON GENETIC-LOCUS AND ARE TRANSCRIPTIONALLY AND OR POSTTRANSCRIPTIONALLY REGULATED DURING T-CELL DEVELOPMENT [J].
CLAYTON, LK ;
DADAMIO, L ;
HOWARD, FD ;
SIEH, M ;
HUSSEY, RE ;
KOYASU, S ;
REINHERZ, EL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5202-5206
[9]   STRUCTURAL MUTATIONS OF THE T-CELL RECEPTOR ZETA-CHAIN AND ITS ROLE IN T-CELL ACTIVATION [J].
FRANK, SJ ;
NIKLINSKA, BB ;
ORLOFF, DG ;
MERCEP, M ;
ASHWELL, JD ;
KLAUSNER, RD .
SCIENCE, 1990, 249 (4965) :174-177
[10]  
GARDNER PA, 1988, J BIOL CHEM, V264, P1068